Castle Biosciences, Inc.CSTLNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P25
Within normal range
vs 2Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-22.48%
2024289.85%
202359.30%
2022-110.48%
2021-539.30%
2020-15.86%
2019148.35%
20181.23%
20170.00%